Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Potential COVID-19 therapeutics from a rare disease: weaponizing lipid dysregulation to combat viral infectivity
Stephen L. Sturley, Tamayanthi Rajakumar, Natalie Hammond, et al.
Journal of Lipid Research (2020) Vol. 61, Iss. 7, pp. 972-982
Open Access | Times Cited: 49

Showing 1-25 of 49 citing articles:

Lipolysis: cellular mechanisms for lipid mobilization from fat stores
G Grabner, Hao Xie, Martina Schweiger, et al.
Nature Metabolism (2021) Vol. 3, Iss. 11, pp. 1445-1465
Open Access | Times Cited: 440
A genome-wide CRISPR screen identifies host factors that regulate SARS-CoV-2 entry
Yunkai Zhu, Fei Feng, Gaowei Hu, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 242
Cholesterol, lipoproteins, and COVID-19: Basic concepts and clinical applications
Eva Kočar, Tadeja Režen, Damjana Rozman
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids (2020) Vol. 1866, Iss. 2, pp. 158849-158849
Open Access | Times Cited: 136
Dissecting lipid metabolism alterations in SARS-CoV-2
Ilaria Casari, Marcello Manfredi, Pat Metharom, et al.
Progress in Lipid Research (2021) Vol. 82, pp. 101092-101092
Open Access | Times Cited: 107
Cepharanthine: a review of the antiviral potential of a Japanese-approved alopecia drug in COVID-19
Moshe Rogosnitzky, Paul Okediji, Igor Koman
Pharmacological Reports (2020) Vol. 72, Iss. 6, pp. 1509-1516
Open Access | Times Cited: 106
Cholesterol-Rich Lipid Rafts as Platforms for SARS-CoV-2 Entry
Selvin Noé Palacios-Rápalo, Luis Adrián De Jesús‐González, Carlos Daniel Cordero‐Rivera, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 88
The roles of lipids in SARS-CoV-2 viral replication and the host immune response
Katherine N. Theken, Soon Yew Tang, Shaon Sengupta, et al.
Journal of Lipid Research (2021) Vol. 62, pp. 100129-100129
Open Access | Times Cited: 70
Anti-Coronavirus Vaccines: Past Investigations on SARS-CoV-1 and MERS-CoV, the Approved Vaccines from BioNTech/Pfizer, Moderna, Oxford/AstraZeneca and others under Development Against SARSCoV- 2 Infection
Michele Costanzo, Maria Anna Rachele De Giglio, Giovanni N. Roviello
Current Medicinal Chemistry (2021) Vol. 29, Iss. 1, pp. 4-18
Closed Access | Times Cited: 55
Coronavirus Infection and Cholesterol Metabolism
Jun Dai, Huan Wang, Ying Liao, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 46
Cholesterol and COVID-19—therapeutic opportunities at the host/virus interface during cell entry
Thomas Grewal, Mai Khanh Linh Nguyen, Christa Buechler
Life Science Alliance (2024) Vol. 7, Iss. 5, pp. e202302453-e202302453
Open Access | Times Cited: 8
Role of Endolysosomes in Severe Acute Respiratory Syndrome Coronavirus-2 Infection and Coronavirus Disease 2019 Pathogenesis: Implications for Potential Treatments
Nabab Khan, Xuesong Chen, Jonathan D. Geiger
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 55
The S1/S2 boundary of SARS-CoV-2 spike protein modulates cell entry pathways and transmission
Yunkai Zhu, Fei Feng, Gaowei Hu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 54
COVID‐19 metabolism: Mechanisms and therapeutic targets
Tianshi Wang, Ying Cao, Haiyan Zhang, et al.
MedComm (2022) Vol. 3, Iss. 3
Open Access | Times Cited: 33
New insights into the role of endosomal proteins for African swine fever virus infection
Miguel Ángel Cuesta-Geijo, Isabel García-Dorival, Ana del Puerto, et al.
PLoS Pathogens (2022) Vol. 18, Iss. 1, pp. e1009784-e1009784
Open Access | Times Cited: 29
Generation of RNA aptamers against chikungunya virus E2 envelope protein
Kaku Goto, R. S. Amano, Ichinose Akiko, et al.
Journal of Virology (2025)
Closed Access
Pathways to Severe COVID‐19 for People with Obesity
Robert W. O’Rourke, Carey N. Lumeng
Obesity (2020) Vol. 29, Iss. 4, pp. 645-653
Open Access | Times Cited: 43
SARS-CoV-2 Neuronal Invasion and Complications: Potential Mechanisms and Therapeutic Approaches
Olivia Swain, Sofia K. Romano, Ritika Miryala, et al.
Journal of Neuroscience (2021) Vol. 41, Iss. 25, pp. 5338-5349
Open Access | Times Cited: 38
Lipid‐based therapies against SARS‐CoV‐2 infection
Eman Humaid Alketbi, Rania Hamdy, Abdalla El‐Kabalawy, et al.
Reviews in Medical Virology (2021) Vol. 31, Iss. 5, pp. 1-13
Open Access | Times Cited: 35
Therapeutic Potential of Alpha-Lipoic Acid in Viral Infections, including COVID-19
Stela Dragomanova, Simona Miteva, Ferdinando Nicoletti, et al.
Antioxidants (2021) Vol. 10, Iss. 8, pp. 1294-1294
Open Access | Times Cited: 32
An overview of the role of Niemann-pick C1 (NPC1) in viral infections and inhibition of viral infections through NPC1 inhibitor
Ahmad Irfan, Seyede Narges Fatemi, Mohammad Ghaheri, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 13
Bis(monoacylglycero)phosphate, an important actor in the host endocytic machinery hijacked by SARS-CoV-2 and related viruses
Céline Luquain‐Costaz, Maxence Rabia, Françoise Hullin‐Matsuda, et al.
Biochimie (2020) Vol. 179, pp. 247-256
Open Access | Times Cited: 27
Identification of Niemann-Pick C1 protein as a potential novel SARS-CoV-2 intracellular target
Isabel García-Dorival, Miguel Ángel Cuesta-Geijo, Lucía Barrado-Gil, et al.
Antiviral Research (2021) Vol. 194, pp. 105167-105167
Open Access | Times Cited: 26
Evaluating cepharanthine analogues as natural drugs against SARS‐CoV‐2
Atsushi Hijikata, Clara Shionyu‐Mitsuyama, Setsu Nakae, et al.
FEBS Open Bio (2021) Vol. 12, Iss. 1, pp. 285-294
Open Access | Times Cited: 25
Transcriptomic profiling and genomic mutational analysis of Human coronavirus (HCoV)-229E -infected human cells
Nehemya Friedman, Jasmine Jacob‐Hirsch, Yaron Drori, et al.
PLoS ONE (2021) Vol. 16, Iss. 2, pp. e0247128-e0247128
Open Access | Times Cited: 18
Endolysosomal cholesterol export: More than just NPC1
Albert Lu
BioEssays (2022) Vol. 44, Iss. 10
Open Access | Times Cited: 13
Page 1 - Next Page

Scroll to top